UPLOAD Filing
InflaRx N.V.
Date: June 11, 2025 · CIK: 0001708688 · Accession: 0000000000-25-006154
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-38283
Letter
Re: InflaRx N.V. Form 20-F for Fiscal Year Ended December 31, 2024 File No. 001-38283 Dear Thomas Taapken:
June 11, 2025
Thomas Taapken Chief Financial Officer InflaRx N.V. Winzerlaer Str. 2 07745 Jena, Germany
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 11, 2025 Thomas Taapken Chief Financial Officer InflaRx N.V. Winzerlaer Str. 2 07745 Jena, Germany Re: InflaRx N.V. Form 20-F for Fiscal Year Ended December 31, 2024 File No. 001-38283 Dear Thomas Taapken: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>